Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,361Revenue $M356Net Margin (%)-16.3Altman Z-Score53.1
Enterprise Value $M4,251EPS $-0.7Operating Margin %-16.1Piotroski F-Score6
P/E(ttm)--Beneish M-Score-3.9Pre-tax Margin (%)-16.2Higher ROA y-yN
Price/Book22.610-y EBITDA Growth Rate %-23.7Quick Ratio2.9Cash flow > EarningsY
Price/Sales11.95-y EBITDA Growth Rate %-27.5Current Ratio3.5Lower Leverage y-yY
Price/Free Cash Flow215y-y EBITDA Growth Rate %--ROA % (ttm)-28.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-37.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M81.3ROIC % (ttm)-85.2Gross Margin Increase y-yY

Gurus Latest Trades with DXCM

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DXCMMario Gabelli 2015-12-31 Reduce$70.65 - $88.83
($83.22)
$ 53.65-36%Reduce -2.20%44,400
DXCMRon Baron 2015-09-30 Reduce$79.36 - $101.91
($89.24)
$ 53.65-40%Reduce -0.51%1,330,742
DXCMMario Gabelli 2015-09-30 Reduce$79.36 - $101.91
($89.24)
$ 53.65-40%Reduce -10.63%45,400
DXCMRon Baron 2015-06-30 Reduce$61.49 - $79.98
($70.13)
$ 53.65-23%Reduce -0.06%1,337,607
DXCMJoel Greenblatt 2015-03-31 Sold Out -0.0044%$54.21 - $64.42
($60.43)
$ 53.65-11%Sold Out0
DXCMRon Baron 2015-03-31 Reduce$54.21 - $64.42
($60.43)
$ 53.65-11%Reduce -0.17%1,338,407
DXCMMario Gabelli 2015-03-31 Reduce$54.21 - $64.42
($60.43)
$ 53.65-11%Reduce -1.55%50,800
DXCMMario Gabelli 2014-12-31 Reduce$40.37 - $58.3
($49.09)
$ 53.659%Reduce -21.82%51,600
DXCMJoel Greenblatt 2014-12-31 Buy $40.37 - $58.3
($49.16)
$ 53.659%New holding9,915
DXCMJoel Greenblatt 2014-09-30 Sold Out $35.35 - $45.89
($41.06)
$ 53.6531%Sold Out0
DXCMJoel Greenblatt 2014-06-30 Buy $29.68 - $41.95
($35.37)
$ 53.6552%New holding8,033
DXCMGeorge Soros 2013-09-30 Sold Out -0.02%$21.78 - $29.19
($25.33)
$ 53.65112%Sold Out0
DXCMGeorge Soros 2013-03-31 Buy 0.02%$13.59 - $17.05
($15.22)
$ 53.65252%New holding100,000
DXCMRon Baron 2012-12-31 Buy 0.11%$12.3 - $14.95
($13.39)
$ 53.65301%New holding1,250,000
DXCMGeorge Soros 2011-09-30 Sold Out -0.0025%$10.3 - $15.66
($12.98)
$ 53.65313%Sold Out0
DXCMGeorge Soros 2011-06-30 Buy $13.05 - $16.72
($15.24)
$ 53.65252%New holding12,500
DXCMMario Gabelli 2011-03-31 Reduce-0.01%$13.3 - $15.79
($14.39)
$ 53.65273%Reduce -55.46%77,500
DXCMGeorge Soros 2011-03-31 Sold Out $13.3 - $15.79
($14.39)
$ 53.65273%Sold Out0
DXCMGeorge Soros 2010-09-30 Reduce$10.76 - $14.06
($12.31)
$ 53.65336%Reduce -43.37%14,100
DXCMGeorge Soros 2010-06-30 Buy 0.01%$9.22 - $11.65
($10.48)
$ 53.65412%New holding24,900
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DXCM is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DXCM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DOUBLEDAY RICHARDEVP, Chief Commercial Officer 2016-01-25Sell1,666$73.34-26.85view
Pacelli Steven RobertEVP, Strategy & Corp. Dev. 2016-01-25Sell10,300$73.24-26.75view
ROPER JESSSVP, CFO 2016-01-22Sell3,518$72.97-26.48view
SAYER KEVIN RPresident & CEO 2016-01-20Sell7,000$75-28.47view
VALDES JORGE ACTO 2016-01-12Sell7,251$79.77-32.74view
LISTER JOHNSr. VP, General Counsel 2016-01-08Sell3,560$82.57-35.02view
Pacelli Steven RobertEVP, Strategy & Corp. Dev. 2015-12-23Sell14,000$82.26-34.78view
DOUBLEDAY RICHARDEVP, Chief Commercial Officer 2015-12-23Sell1,666$82.22-34.75view
ROPER JESSSVP, CFO 2015-12-22Sell3,417$81.19-33.92view
Balo Andrew KEVP, Clinical, Regulatory 2015-12-17Sell7,500$82.52-34.99view

Quarterly/Annual Reports about DXCM:

News about DXCM:

Articles On GuruFocus.com
Baron Funds Comments on DexCom Inc. Jan 14 2016 
Investing for Lower Risk Long-Term Growth in a Volatile Asset Class - Baron Funds Winter Newsletter Jan 14 2016 
Top Weekly Insider Sells Highlights Sep 15 2015 
Weekly CFO Sells Highlight: Gilead Sciences, DexCom, and Palo Alto Networks Sep 13 2015 
Panic-Proofing the Small Investor Aug 26 2015 
Baron Funds Comments on DexCom Inc. Aug 19 2015 
Weekly CFO Sells Highlight: Cigna Corp, Comcast Corp, and DexCom Inc. Jul 20 2015 
Weekly Insider Sells Highlight: GILD, AXTA, GME, DXCM Jul 14 2015 
Weekly CFO Sells Highlight: Axalta Coating Systems Ltd, Palo Alto Networks Inc, DexCom Inc. Jul 13 2015 
Dexcom’s Smart Glucose Monitoring System Receives FDA Approval Jan 27 2015 

More From Other Websites
Dexcom downgraded by Robert W. Baird Feb 08 2016
DEXCOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement Feb 04 2016
DexCom Announces Upcoming Conference Presentation Jan 29 2016
DexCom Announces Upcoming Conference Presentation Jan 29 2016
Big Pharma's bet on Big Data creates opportunities and risks Jan 26 2016
Big Pharma's bet on Big Data creates opportunities and risks Jan 26 2016
Big Pharma's bet on Big Data creates opportunities and risks Jan 26 2016
DexCom Schedules Fourth Quarter and Full Year 2015 Earnings Release and Conference Call for February... Jan 22 2016
DexCom Schedules Fourth Quarter and Full Year 2015 Earnings Release and Conference Call for February... Jan 22 2016
DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition Jan 12 2016
DexCom Announces Upcoming Conference Presentation Jan 04 2016
DexCom Announces Upcoming Conference Presentation Jan 04 2016
Insight - Beyond Fitbit: The quest to develop medical-grade wearables Dec 18 2015
DexCom, Inc. breached its 50 day moving average in a Bearish Manner : December 14, 2015 Dec 14 2015
DEXCOM INC Financials Dec 08 2015
Is Plum Creek Timber Co. Inc. (PCL) Going to Burn These Hedge Funds? Nov 27 2015
DexCom, Inc. breached its 50 day moving average in a Bullish Manner : November 23, 2015 Nov 23 2015
Why Warren Buffett Would Pay 2X Current Market Price To Own CASM Nov 23 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK